ADLM 2026 Session Recordings list
When possible, sessions presented at ADLM 2026, held July 26 – July 30, 2026, are available as part of the ADLM 2026 Session Recordings. The listing of specific recordings included is below.
Please note that ADLM 2026 Session Recordings are not eligible for continuing education credit.
ADLM 2026 Session Recordings will be available starting September 9, 2026. Individuals that have purchased or been given complimentary access will be notified by email when the recordings are available. Access instructions will be provided at that time. Session recordings will be accessible through July 31, 2027. View purchase details.
Below is a full list of sessions. Those that may not be included in the session recordings due to speaker requests or other limitations are indicated in red. A final list of included sessions will be available by August 12.
Jump to:
Plenary and Meet-the-Expert sessions
11001 Diabetes prevention and treatment: A personal odyssey from bench to bedside
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Diabetes prevention and treatment: A personal odyssey from bench to bedside
David Nathan, MD, Massachusetts General Hospital
62001 Diabetes prevention and treatment: A personal odyssey from bench to bedside (Meet-the-expert)
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Diabetes prevention and treatment: A personal odyssey from bench to bedside (Meet-the-expert)
David Nathan, MD, Massachusetts General Hospital
12001 Laboratory diagnostics for space medicine
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Laboratory diagnostics for space medicine
Kathleen McMonigal, MD, NASA Johnson Space Center Clinical Laboratory
13001 Alzheimer disease biomarkers in Down syndrome
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Alzheimer disease biomarkers in Down syndrome
Elizabeth Head, PhD, MA, University of California, Irvine
14001 Advances in screening for cervical cancer both in the United States and globally
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Advances in screening for cervical cancer both in the United States and globally
Leeya Pinder, MD, MPH, University of Cincinnati
15001 Mass spectrometry-based discovery and translation of novel biomarkers into immune-based therapies for cancer
Moderator: Jason Park, MD, PhD, DABCC, UT Southwestern Medical Center
Speaker(s):
Mass spectrometry-based discovery and translation of novel biomarkers into immune-based therapies for cancer
Arun Wiita, MD, PhD, University of California, San Francisco
Scientific Sessions and Special Sessions
MONDAY, JULY 27, 2026
12002 Disruptive Technology Award Competition
Moderator: Stephen Master, MD, PhD, FADLM, Children's Hospital of Philadelphia
SRA-O Student Oral Presentation Competition
Moderator: Robert Nerenz, PhD, DABCC, FADLM, Medical College of Wisconsin
32101 Biomarkers of traumatic brain injury: New guidance from the National Institute of Neurological Disorders and Stroke
Moderator: Alan Wu, PhD, University of California at San Francisco
Speaker(s):
The NIH-NINDS traumatic brain injury classification and nomenclature initiative
Frederick Korley, MD, PhD, University of Michigan
Recent updates from the HeadSMART II clinical and biomarker trial
Frank Peacock, MD, Baylor College of Medicine
Analytical requirements for TBI biomarker testing and use of results reporting based on biological variation
Alan Wu, PhD, University of California at San Francisco
32102 Pediatric reference intervals: Progress, challenges, and future perspectives
Moderator: Kwaku Baryeh, PhD, DABCC, Eli Lilly and Company
Speaker(s):
AACC/ADLM/CDC/NHANES: The alphabet soup of advocating for better pediatric reference intervals in Congress and the court of public opinion
Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
CALIPER: A global benchmark for direct pediatric reference interval programs - development, challenges, and keys to success
Khosrow Adeli, PhD, DABCC, FADLM, FCACB, The Hospital for Sick Children
Big data meets small patients: From algorithm to application of indirect reference intervals in pediatric laboratory testing
Kelly Doyle, PhD, DABCC, FADLM, University of Utah
32103 Moving beyond creatinine to evaluate kidney function through novel biomarker panels
Moderator: Jesse Seegmiller, PhD, DABCC, University of Minnesota
Speaker(s):
A new approach to estimating glomerular filtration rate (eGFR) through the paneling of novel biomarkers
Nora Fino, PhD, University of Utah
Renal tubular secretion evaluation in patients to predict adverse event outcomes
Joachim Ix, MD, University of California, San Diego
Translation of metabolomic findings into quantitative renal function panels using liquid chromatography tandem mass spectrometry (LC-MS/MS)
Jesse Seegmiller, PhD, DABCC, University of Minnesota
32104 Wearable devices for diagnostics, is this point-of-care testing?
Moderator: Julie Shaw, PhD, The Ottawa Hospital/University of Ottawa/Eastern Ontario Regional Laboratories Association
Speaker(s):
Continuous glucose monitoring devices as an example of successful wearable device use in clinical settings
Julie Shaw, PhD, The Ottawa Hospital/University of Ottawa/Eastern Ontario Regional Laboratories Association
Use of artificial intelligence to enable clinical use of data from smart and wearable devices
Nam Tran, PhD, MS, FADLM, HCLD(ABB), MLS(ASCP)cm, University of Pittsburgh
Patient generated health data and delivery of personalized care
Sunita Mishra, MD, MBA, Neko Health
32105 Bad, better, best: Putting leadership behaviors to the test
Moderator: T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine/SSM Health
Speaker(s):
Introduction, overview, and facilitation
T. Scott Isbell, PhD, DABCC, FADLM, Saint Louis University School of Medicine/SSM Health
Point
Shannon Haymond, PhD, DABCC, FADLM, Ann & Robert H. Lurie Children's Hospital of Chicago
Counterpoint
Chris McCudden, PhD, DABCC, FADLM, FCACB, The Ottawa Hospital/University of Ottawa
32106 Tick-borne diseases: Beyond Lyme disease
Moderator: Kyle Rodino, PhD, D(ABMM), University of Pennsylvania
Speaker(s):
Tick-borne diseases in the United States and diagnostic approaches
Kyle Rodino, PhD, D(ABMM), University of Pennsylvania
Interesting and challenging tick-borne disease cases
Marc Couturier, PhD, D(ABMM), MaineHealth
New and novel molecular diagnostics for tick-borne diseases
Blake Buchan, PhD, D(ABMM), The Medical College of Wisconsin
32107 The bright future of radiopharmaceutical imaging and therapy
Moderator: Paul Jannetto, PhD, DABCC, FADLM, MT(ASCP), Mayo Clinic
Speaker(s):
Radiopharmaceutical imaging and therapy is a great opportunity for collaboration
Geoffrey Johnson, MD, PhD, Mayo Clinic
32108 Beyond clinical care: Ethical, legal, and social implications of third-party uses of DNA
Moderator: Christi Guerrini, JD, MPH, Baylor College of Medicine
Speaker(s):
Beyond borders: The practical, ethical, and policy landscape of humanitarian uses of DNA for human identification
Sara Huston, MS, Ann & Robert H. Lurie Children's Hospital of Chicago
How fair is actuarial fairness? Insurer use of genetic data
Anya Prince, JD, MPP, University of Iowa
Law enforcement use of genetic data in criminal investigations: Investigative genetic genealogy and beyond
Christi Guerrini, JD, MPH, Baylor College of Medicine
32109 Current challenges in workplace and clinical drug testing: Urine substitution, urine adulteration, designer drugs, and more!
Moderator: Gwendolyn McMillin, PhD, DABCC, NMS Labs
Speaker(s):
How people try to beat compliance drug testing: The critical role of LC-MS/MS analysis
Jessica Boyd, PhD, DABCC, University of Utah/ARUP Laboratories
How people try to beat workplace drug testing? Currently available methods to identify synthetic urine and urinary adulterants
Amitava Dasgupta, PhD, DABCC, University of Kansas Medical School
Changes in the drug supply and drug use patterns: How laboratories can be informed and respond
Gwendolyn McMillin, PhD, DABCC, NMS Labs
32221 Enhancing CVD care: Leveraging new AHA/ACC guidelines, treatments, risk assessments, and innovative functional assays
Moderator: Mahesheema Ali, PhD, DABCC, FADLM, NRCC, MetroHealth System
Speaker(s):
Advancing CDC CVD biomarkers standardization program in response to changes in CVD care and management
Hubert Vesper, PhD, Centers for Disease Control and Prevention
New methods for calculating or measuring low-density lipoprotein-cholesterol and other related cardiovascular biomarkers
Anna Wolska, PhD, National Institutes of Health
Advanced and new diagnostic tests for cardiovascular risk assessment
Alan Remaley, MD, PhD, National Institutes of Health
32222 Newborn screening across Europe and the USA, what can we learn from each other?
Moderator: Van Leung-Pineda, PhD, DABCC, Children's Healthcare of Atlanta
Speaker(s):
Advancing newborn screening in the United States: Practical lessons and innovations
Mei Baker, MD, University of Wisconsin School of Medicine and Public Health
Innovations in European newborn screening programs: from standard biochemical panels to genomic approaches
Emeline Gernez, MD, Lille University Hospital
Implementing newborn screening in the 21st Century
Van Leung-Pineda, PhD, DABCC, Children's Healthcare of Atlanta
32223 Biomarkers for acute kidney injury: From physiology to practice with new clinical guidance
Moderator: Amy Pyle-Eilola, PhD, DABCC, FADLM, Nationwide Children's Hospital
Speaker(s):
Kidney function and injury biomarkers: From evidence to implementation in pediatric clinical care
Diana Zepeda-Orozco, MD, Nationwide Children's Hospital
Kidney diseases improving global outcomes (KDIGO) clinical practice guideline update on use of biomarkers for AKI
Matthew James, MD, PhD, University of Calgary
Validating and implementing novel kidney biomarkers in a clinical lab
Amy Pyle-Eilola, PhD, DABCC, FADLM, Nationwide Children's Hospital
32224 POCT across the continuum: From real-time results to measurable impact
Moderator: Min Yu, MD, PhD, MBA, DABCC, FADLM, Care New England Health System
Speaker(s):
Making POCT count: Right now, done right
Min Yu, MD, PhD, MBA, DABCC, FADLM, Care New England Health System
Investigating assay bias: What to do when testing personnel sound the alarm
Nicholas Larkey, PhD, DABCC, NRCC, FADLM, CPP, University of Virginia
It’s not you, it’s me: Standardization between POC and other chemistry sections
Robert Maynard, PhD, DABCC, NRCC, University of Kentucky
32225 Life after AI deployment: A conversation on effective real-world performance monitoring
Moderator: Nicholas Spies, MD, University of Utah/ARUP Laboratories
Speaker(s):
AI performance monitoring: Tools of the trade
Nicholas Spies, MD, University of Utah/ARUP Laboratories
AI in the trenches: How labs monitor what matters
Christopher Garcia, MD, Mayo Clinic
32226 First, do no harm: Ethics at the crossroads of scientific integrity, AI, and DTC testing
Moderator: Joe Wiencek, PhD, DABCC, NRCC, FADLM, Vanderbilt University School of Medicine
Speaker(s):
Ethical foundations and scientific integrity in laboratory medicine
Joe Wiencek, PhD, DABCC, NRCC, FADLM, Vanderbilt University School of Medicine
Navigating data privacy and security in the use of AI for lab medicine
Sarah Wheeler, PhD, FADLM, University of Pittsburgh Medical Center
From access to action: Ethical considerations in direct-to-consumer laboratory testing
Melissa Budelier, PhD, DABCC, TriCore Reference Laboratories
32227 Measuring what matters: A practical framework for advancing equitable healthcare, diversity, equity, and inclusion in laboratory medicine
Moderator: Jaime Noguez, PhD, DABCC, University Hospitals Cleveland Medical Center
Speaker(s):
Measuring and sustaining DEI impact: Tools and metrics for evaluating DEI initiatives and linking them to patient outcomes
Jaime Noguez, PhD, DABCC, University Hospitals Cleveland Medical Center
Equitable laboratory practices: Approaches to ensure equitable access to testing and laboratory services across patient populations
Zahra Shajani-Yi, PhD, DABCC, NRCC, FADLM, Labcorp
Workforce Diversity and Inclusive Environments: Strategies to recruit, retain, and support a diverse laboratory workforce while cultivating an inclusive culture that empowers all staff
Sean Campbell, PhD, DABCC, FADLM, Sinai Health System
32228 A rapid-fire overview aimed at striking a balancing between patient care, cost, and analytical complexity in urine toxicology
Moderator: Frederick Strathmann, PhD, MBA, DABCC, MOBILion Systems
Speaker(s):
The case for POC urine drug testing: Maximum value and lowest cost
Matthew Shashack, PhD, DABCC, University of Oklahoma Health Campus
Immunoassay only for toxicology workflows
William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
Pediatric urine toxicology testing: In need of change
Stanley Lo, PhD, Children’s Wisconsin
An in-house approach to urine drug testing
Cierra Sharp, PhD, DABCC, NRCC, Norton Healthcare
Direct-to-definitive results = Definitive patient care
Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
High value, high impact: The case for direct mass spectrometry in urine drug testing
Berna Aslan, MD, DABCC, FADLM, NL Health Services/Memorial University of Newfoundland
Context, complexity, and cost: What separates clinical and forensic workflows
Hannah Brown, PhD, Hennepin Healthcare
“Fit for purpose" toxicology testing
Kara Lynch, PhD, University of California, San Francisco
The payor perspective in urine toxicology screening and confirmation
Geoff Baird, MD, PhD, DABCC, University of Washington, Department of Laboratory Medicine and Pathology
Best practices for urine toxicology billing and coding: Aligning process and policy for streamlined workflows
Ann Lambrix, MS, Lighthouse Lab Services
32442 Expecting the best: Laboratory issues in the diagnosis and management of diabetes in pregnancy
Moderator: David Sacks, MBChB, FACP, FRCPath, National Institutes of Health
Speaker(s):
Diagnosis of gestational diabetes: Is OGTT the right test?
David Sacks, MBChB, FACP, FRCPath, National Institutes of Health
Monitoring glycemia in pregnancy: How did we arrive at the current targets?
Claire Meek, MBChB, PhD, MRCP, FRCPath, University of Leicester/Leicester Diabetes Research Centre
Postpartum glycemic monitoring: Rethinking the OGTT
Aoife Egan, PhD, Mayo Clinic
32443 Adopting ferritin thresholds over reference intervals to diagnose iron deficiency
Moderator: Edward Wong, MD, Quest Diagnostics
Speaker(s):
Lessons from studies of iron deficiency in blood donors
Alan Mast, PhD, MD, Versiti Blood Research Institute
Ferritin in flux: Evaluating reference interval variation, methodological differences, and the case for unified clinical cutoffs
Dana Nyholt, PhD, DABCC, Mount Sinai Hospital
Raising the bar: Evidence-based ferritin clinical decision limits to improve detection of iron deficiency
Michelle Sholzberg, MD, St Michael's Hospital
32444 Navigating interdisciplinary collaboration to support innovations in liver transplantation
Moderator: Anastasia Gant Kanegusuku, PhD, DABCC, Loyola University Medical Center
Speaker(s):
Normothermic machine perfusion: Transforming the landscape of liver transplantation
Koji Hashimoto, MD, PhD, Cleveland Clinic
Activity levels of organox use and outcomes in an academic liver transplantation program
Phillip DeChristopher, MD, PhD, FASCP, FCAP, Loyola University Medical Center
Navigating interdisciplinary collaboration to support innovations in liver transplantation
Anastasia Gant Kanegusuku, PhD, DABCC, Loyola University Medical Center
32445 Navigating reimbursement and coding: The basics, AI, and emerging healthcare technologies
Moderator: Mahesheema Ali, PhD, DABCC, FADLM, NRCC, MetroHealth System
Speaker(s):
Reimbursement in laboratory medicine: Identifying denials and optimizing revenue recovery
Mahesheema Ali, PhD, DABCC, FADLM, NRCC, MetroHealth System
Laboratory billing and coding: An introduction and applications in AI and emerging technologies
Jonathan Genzen, MD, PhD, University of Utah/ARUP Laboratories
32446 Petri dishes and pixels: Applying digital imaging solutions to contemporary clinical microbiology practice
Moderator: Daniel Rhoads, MD, Cleveland Clinic
Speaker(s):
Digital imaging and machine learning theory and application in the clinical laboratory
Thomas Durant, MD, Yale School of Medicine
AI in the real world: Inside one lab’s journey toward digital parasitology
Anisha Misra, PhD, Cleveland Clinic
Improving efficiency and quality using digital bacteriology
Daniel Rhoads, MD, Cleveland Clinic
32447 Clocking biological time: Measuring, standardizing, and influencing biological age
Moderator: Amy Karger, MD, PhD, FCAP, University of Minnesota
Speaker(s):
The landscape of biological aging: Overview of the aging metrics used in research studies
Bharat Thyagarajan, MD, PhD, University of Minnesota
The standardization challenge: Harmonizing the measurement of epigenetic aging
Jessica Faul, PhD, University of Michigan
Can we intervene on biological aging? Targets, mechanisms, and measurable change
Sithara Vivek, PhD, University of Minnesota
32448 It was Miss Peacock at the analyzer with the bad QC! Laboratory medicine Clue: Root cause analysis edition
Moderator: Jane Dickerson, PhD, DABCC, Seattle Children's Hospital
Speaker(s):
The mystery of mistaken identities
Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
The curious case of QC failure
Jane Dickerson, PhD, DABCC, Seattle Children's Hospital
The strange affair of intercepted intelligence
Steven Cotten, PhD, DABCC, NRCC, FADLM, University of North Carolina
32449 Beyond the SOP: Point–counterpoint on gray zone lab decisions
Moderator: Jeff Meeusen, PhD, DABCC, Mayo Clinic
Speaker(s):
The conversation behind the test result: Judgment, context, and care
Yachana Kataria, PhD, DABCC, Boston Medical Center
Guardrails first: Why standards matter in exceptional testing
Khushbu Patel, PhD, DABCC, FADLM, Children's Hospital of Philadelphia
Exceptions in policies: When flexibility serves patient care
Jeff Meeusen, PhD, DABCC, Mayo Clinic
TUESDAY, JULY 28, 2026
33101 Clinical Chemistry Journal hot topics: New approaches to personalized reference ranges
Moderator: Eric Kilpatrick, MBChB, FRCPath, FRCP, Manchester University NHS Foundation Trust
Speaker(s):
From biological variation to personalized reference intervals: A new paradigm for interpreting laboratory results
Abdurrahman Coskun, MD, Acibadem Mehmet Ali Aydinlar University
Moving from population based to personalized reference intervals using real-world reference change values
Eirik Roys, MSc, Haukeland University Hospital
33102 Academy distinguished abstracts: Precision oncology diagnostics: AI, blood-based biomarkers, and longitudinal monitoring
Moderator: Khosrow Adeli, PhD, DABCC, FADLM, FCACB, The Hospital for Sick Children
Speaker(s):
Machine learning–enhanced diagnostic performance of plasma metanephrines in PPGL: A large-scale real-world clinical cohort study
Se-eun Koo, MD, Samsung Medical Center
Integrating ctDNA monitoring with peripheral immunophenotyping to define acquired immunotherapy resistance in metastatic melanoma
Annalara Fischer, PhD, University of Louisville
DNA methylation profiling of peripheral blood mononuclear cells unveils systemic immune dysregulation and enables multi-cancer early detection
Shujun Zhang, , Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong
Clinical validation of high-resolution mass spectrometry for blood-based minimal residual disease detection to reduce the need for bone marrow aspiration
Ryan Pearce, PhD, Mayo Clinic
33103 Clinical laboratory logic showdown: A game of strategy and speed in critical thinking and decision-making
Moderator: Alec Saitman, PhD, DABCC, Oregon Health and Science University
Speaker(s):
Decoding discordance: Preanalytical vs analytical errors in chemistry
Jaime Noguez, PhD, DABCC, University Hospitals Cleveland Medical Center
When to stop the analyzer and troubleshoot
Aaron Geno, PhD, DABCC, Dartmouth Health
Lightning round: Troubleshooting under pressure
Alec Saitman, PhD, DABCC, Oregon Health and Science University
33104 Update on clinical assay issues: What endocrinologists will frequently ask you
Moderator: David Sacks, MBChB, FACP, FRCPath, National Institutes of Health
Speaker(s):
Clinical and Prognostic Values of AntiTSH Receptor Antibody Measurements- Are They all Equal?
Gregory Brent, MD, University of California-Los Angeles David Geffen School of Medicine
Utility and Pitfalls of Biomarkers for Neuroendocrine Tumors
Jaydira Del Rivero, MD, National Cancer Institute/National Institutes of Health
Caveats of Renin Assays- Implications for Secondary Hypertension Screening
Vivek Bhalla, MD, Stanford University School of Medicine
33105 Transforming Alzheimer’s care: Implications of new clinical guidance
Moderator: Mari DeMarco, PhD, DABCC, FADLM, FCACB, St. Paul's Hospital
Speaker(s):
New guidance for the use of amyloid and tau positron emission tomography imaging
Gloria Chiang, MD, Weill Cornell Medicine
New guidance for clinicians on the use of blood biomarkers
Hamid Okhravi, MD, Eastern Virginia Medical School
New guidance for clinical laboratories on the implementation of biofluid biomarkers
Mari DeMarco, PhD, DABCC, FADLM, FCACB, St. Paul's Hospital
33106 Behind the bench: Navigating safety and science in prion disease testing
Moderator: John Mills, PhD, DABCC, DABMGG, Mayo Clinic
Speaker(s):
Modern Diagnostics for Human Prion Disease: RT-QuIC, Biomarkers, and Clinical Interpretation
Shashirekha Shetty, PhD, Case Western Reserve University
Practical Biosafety and Risk-Based Management of Suspected Prion Specimens Across the Clinical Laboratory
John Mills, PhD, DABCC, DABMGG, Mayo Clinic
The Human Side of Prion Disease: Patient Journey, Diagnostic Delays, and Opportunities for Laboratory Impact
Sonia Vallabh, PhD, JD, Broad Institute
33107 I spy with my lab inspector eye: Accreditation citation risks
Moderator: Kacy Peterson, DCLS, MBA, MLS(ASCP)cm, DLM(ASCP), Avera Health
Speaker(s):
Inspector Gadget's guide to ISO 15189
Kacy Peterson, DCLS, MBA, MLS(ASCP)cm, DLM(ASCP), Avera Health
Watson, we have a problem
Elia Mears, MS, MT(ASCP), Joint Commission on Accreditation of Healthcare Organizations
Nancy Drew with an inspection walk through
Carrie Leipzig, BA, MLS(ASCP), Fairview Health Services
33108 ADLM Healthcare Forum: Future regulation and reimbursement for software and AI in the clinical laboratory
Moderator: Jonathan Genzen, MD, PhD, University of Utah/ARUP Laboratories
Speaker(s):
Regulation of medical and laboratory software in the era of artificial intelligence
Jonathan Genzen, MD, PhD, University of Utah/ARUP Laboratories
Cost and reimbursement considerations for algorithms and artificial intelligence in laboratory medicine
William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
Development, validation, and implementation of AI algorithms in laboratory medicine: Learning from digital pathology
Nam Tran, PhD, MS, FADLM, HCLD(ABB), MLS(ASCP)cm, University of Pittsburgh
33109 Recreational use of nitrous oxide: Clinical cases and laboratory detection
Moderator: Christine Snozek, PhD, DABCC, FADLM, Mayo Clinic
Speaker(s):
Recreational nitrous oxide use: No laughing matter
Christine Snozek, PhD, DABCC, FADLM, Mayo Clinic
The toxicology of whippets: Case presentations of whippet intoxication
Hannah Spungen, MD, MPH, UCLA Health
Operationalizing emerging recommendations: Reflex logic and interpretation for nitrous oxide–related laboratory workups
Guillaume Grzych, PhD, PharmD, Centre Hospitalier Universitaire de Lille
33221 Cardiac troponin I utilization: Impactful consequences from lacking standardization and harmonization
Moderator: Robert Christenson, PhD, DABCC, FADLM, FACC, University of Maryland School of Medicine
Speaker(s):
Design and production of a human lithium heparin plasma matrix reference material for high-sensitivity cardiac troponin I comparability
Claudia Swart, PhD, Physical-Technical Federal Institute
Examining reference material 8121’s suitability for harmonizing/standardizing FDA-cleared high-sensitivity cardiac troponin I measurements
Robert Christenson, PhD, DABCC, FADLM, FACC, University of Maryland School of Medicine
Path forward: How can a reference material be applied to standardize/harmonize cardiac troponin I measurements for patient care
Mark Lowenthal, PhD, National Institute of Standards and Technology
33222 The sFlt-1:PlGF ratio in the evaluation of preeclampsia
Moderator: Robert Nerenz, PhD, DABCC, FADLM, Medical College of Wisconsin
Speaker(s):
Preeclampsia from a clinical perspective: Prevention, diagnosis, and management of a complex condition
Anna Palatnik, MD, Medical College of Wisconsin
Preeclampsia pathophysiology: What is the sFlt-1:PlGF ratio and what does it tell us?
Robert Nerenz, PhD, DABCC, FADLM, Medical College of Wisconsin
Preeclampsia biomarkers: Adoption of sFlt-1:PlGF and evaluation of emerging diagnostic tools
Ann Gronowski, PhD, DABCC, Washington University School of Medicine
33223 New innovations and guidelines in hematology/coagulation
Moderator: Edward Wong, MD, Quest Diagnostics
Speaker(s):
Artificial intelligence in hematology labs: From concepts to implementation realities
Amrom Obstfeld, MD, PhD, Children's Hospital of Philadelphia
The feasibility of identifying and quantitating malaria using hematology analyzers: Myth or reality?
Michelle Grant, DO, Geisinger Medical Center
Same assay, new lot, new results? Exploring the reality of reagent variability in coagulation
Kieron Hickey, PhD, Sheffield Teaching Hospitals NHS Foundation Trust
33224 Downtime, not downfall: Strategies for preparedness and recovery of extended downtime and cyberattacks
Moderator: Angeline Glomb, BS, MBA, MLS(ASCP), Ann & Robert H. Lurie Children's Hospital of Chicago
Speaker(s):
LIS go-live, or not
Simone Arvisais-Anhalt, MD, University of California, San Francisco
Lessons from downtime: Sharing of knowledge
Christina Wojewoda, MD, University of Vermont Health
The riskiest hour: Define your plan from hour 1 to 1100
Angeline Glomb, BS, MBA, MLS(ASCP), Ann & Robert H. Lurie Children's Hospital of Chicago
33225 Parasitology in the clinical lab, it’s not just for micro anymore
Moderator: Marc Couturier, PhD, D(ABMM), MaineHealth
Speaker(s):
What the cell is this?
Bobbi Pritt, MD, Mayo Clinic
When gross isn’t gross: How to manage helminth and arthropod specimens in the clinical laboratory
Blaine Mathison, BS, University of Utah/ARUP Laboratories
Don’t make this so apicomplexa
Marc Couturier, PhD, D(ABMM), MaineHealth
33226 Addressing scientific gaps in POCT
Moderator: Nicole Tolan, PhD, DABCC, Washington University School of Medicine
Speaker(s):
Gaps in pediatric POCT
Dennis Dietzen, PhD, DABCC, FADLM, Phoenix Children's Hospital
POCT in resource limited, rural, and remote settings: Gaps in access to care
Julie Shaw, PhD, The Ottawa Hospital/University of Ottawa/Eastern Ontario Regional Laboratories Association
POCT Gaps in Alternative Care Models: Lessons Learned from the Hospital at Home Program
Nicole Tolan, PhD, DABCC, Washington University School of Medicine
33227 How can we make the most of proficiency testing?
Moderator: Joely Straseski, PhD, DABCC, FADLM, MLS(ASCP), University of Utah/ARUP Laboratories
Speaker(s):
Making the most of proficiency testing: Overview and case studies
Joely Straseski, PhD, DABCC, FADLM, MLS(ASCP), University of Utah/ARUP Laboratories
How can matrix-matched and accuracy-based proficiency testing improve patient care?
Andy Hoofnagle, MD, PhD, University of Washington
33228 Academy guidance document on data analytics: Advancing data analytics maturity in the clinical laboratory for a data-driven future
Moderator: Thomas Durant, MD, Yale School of Medicine
Speaker(s):
Vision and strategy: Data analytics in the clinical laboratory
Thomas Durant, MD, Yale School of Medicine
From incident to improvement: Partnering effectively with it to develop data analytics infrastructure
Patrick Mathias, PhD, MD, University of Washington School of Medicine
Developing core skills in data analytics for the clinical laboratorian
Sarah Wheeler, PhD, FADLM, University of Pittsburgh Medical Center
33229 Clinical laboratory realities for effective overdose biosurveillance
Moderator: Frederick Strathmann, PhD, MBA, DABCC, MOBILion Systems
Speaker(s):
Overdose biosurveillance: A laboratory-based surveillance system for nonfatal overdoses
Ewa King, PhD, Association of Public Health Laboratories
Practical implications of participating in a state-led biosurveillance program as an academic medical center
Adina Badea, PhD, DABCC, Brown University Health/Rhode Island Hospital
Collaboration with the Florida public health laboratory for overdose surveillance using residual ED samples
Angela Lauster, MBA, DLM(ASCP), MLS(AMT), Tampa General Hospital
WEDNESDAY, JULY 29, 2026
34101 Cases from the Journal of Applied Laboratory Medicine: Maximizing the impact of the clinical chemistry laboratory on patient management
Moderator: Ian Young, MD, Queen's University Belfast
Speaker(s):
Cases from the Journal of Applied Laboratory Medicine – endocrinology and laboratory stewardship
Allison Chambliss, PhD, DABCC, FADLM, University of California, Los Angeles
Pediatric Cases from the Journal of Applied Laboratory Medicine
Cate Omosule, PhD, DABCC, NRCC, Washington University in St. Louis
Cases from the Journal of Applied Laboratory Medicine – acid-base disturbances and electrolytes
Ian Young, MD, Queen's University Belfast
34102 Hypertensive disorders of pregnancy: Cardiovascular implications
Moderator: Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine
Speaker(s):
Cardiac stress and biomarker dynamics in hypertensive pregnancy
Allan Jaffe, MD, Mayo Clinic
Cardiovascular burden and real-world insights from electronic health record cohorts
Emily Lau, MD, MPH, Mass General Brigham Heart and Vascular Institute
Integrating biomarkers and artificial intelligence for preeclampsia prediction
Zhen Zhao, PhD, DABCC, FADLM, Weill Cornell Medicine
34103 Building a resilient service line: Laboratory growth and integration strategies for multi-site health systems
Moderator: David Shiembob, MBA, C(ASCP), University of Utah/ARUP Laboratories
Speaker(s):
Strategies for integrating laboratory services in growing health systems
David Shiembob, MBA, C(ASCP), University of Utah/ARUP Laboratories
Managing experience, expectations, and expertise in a large networked regional medical center lab
Ryan O'Connell, MD, MBA, University of California, Irvine
Aligning laboratory services in a growing academic medical system
Tara Kasmarek, MBA, UCI Health
34104 Analytically speaking: Interrogation and interpretation of patient test results in modern laboratory medicine
Moderator: Octavia Peck Palmer, PhD, FADLM, University of Pittsburgh Medical Center
Speaker(s):
Panelist 1
Ann Gronowski, PhD, DABCC, Washington University School of Medicine
Panelist 2
Maryam Salehi, PhD, NRCC, FADLM, Emory University School of Medicine-Grady Health System
Panelist 3
Melody Nelson, DCLS, NRCC, MLS(ASCP), The University of Kansas Health System
Panelist 4
Darci Block, PhD, DABCC, Mayo Clinic
34105 The shot not taken: Dangers of declining vaccination rates and impacts to the lab
Moderator: Benjamin Bradley, MD, PhD, University of Utah/ARUP Laboratories
Speaker(s):
Vaccine-preventable diseases: The pediatrician’s view
Denver Niles, MD, D(ABMM), Texas Children's Hospital
Vaccine-preventable diseases: The laboratorian’s view
Benjamin Bradley, MD, PhD, University of Utah/ARUP Laboratories
Vaccine-preventable diseases: The public health view
Anthony Tran, DrPH, D(ABMM), MT(ASCP), California Department of Public Health
34106 The integration journey: Preparing clinical laboratorians for EHR/LIS implementation
Moderator: Michelle Stoffel, MD, PhD, M Health Fairview/University of Minnesota
Speaker(s):
From vision to readiness: Implementation science-informed strategies for successful EHR/LIS integration
Li Zha, PhD, DABCC, NRCC, ACHIP, Boston Children's Hospital
Integrated EHR/LIS implementation: Communication and collaboration under pressure
Simone Arvisais-Anhalt, MD, University of California, San Francisco
Beyond go-live: Sustaining standardization and quality in LIS operations across a health system
Shirley Li, MD, PhD, DABCC, FCACB, The Ohio State University
34107 Critical review and update of clinical guidelines for immune-mediated conditions: ANA reporting, antiphospholipid syndrome and multiple sclerosis
Moderator: Maria Alice Willrich, PhD, DABCC, FADLM, Mayo Clinic
Speaker(s):
Implementing and reviewing the clinical utility of the updated ICAP recommendations for ANA pattern reporting in clinical laboratories
Mark Wener, MD, D(ABMLI), University of Washington Medical Center
Antiphospholipid antibody testing: Laboratory and clinical implications of the 2023 APS/ACR classification criteria
Vijayalakshmi (Viji) Nandakumar, PhD, DABCC, Consultant
The 2024 McDonald criteria and the positive cerebrospinal fluid for diagnosis of multiple sclerosis
Maria Alice Willrich, PhD, DABCC, FADLM, Mayo Clinic
34108 Off the beaten ion path: New directions for clinical mass spectrometry
Moderator: Daniel Holmes, MD, FRCPC, St Paul's Hospital Providence Health Care
Speaker(s):
Clinical deployment of AI decision support for pain management testing in a diagnostic referral centre
Brody Foy, DPhil, University of Washington
That’s a negative: Innovations in MALDI-TOF sample prep permit avoidance of unnecessary urine culture
Michael Chen, MD, MSc, FRCPC, University of British Columbia
Automation in mass spectrometry: DIY to walkway and all that’s in between
Daniel Holmes, MD, FRCPC, St Paul's Hospital Providence Health Care
34221 Patient centric sampling for clinical diagnostics: Overcoming barriers to routine adoption
Moderator: Bradley Collier, PhD, Labcorp
Speaker(s):
Strategies for patient-centric sampling: Barriers to adoption and technology solutions for accessibility and comfort
Sharon Geaghan, MD, Stanford University
Innovation outpacing guidance: Challenges in sample integrity and standardization for patient-centric sampling
Agnes Lenagh, PhD, University of Nebraska Medical Center
Liquid capillary blood in routine clinical laboratories: Clinical utility, advantages, and risks
Alvaro Gonzalez, PhD, Clínica Universidad de Navarra
Lessons learned from decades of experience with capillary microsampling in a pediatric hospital laboratory
Amy Pyle-Eilola, PhD, DABCC, FADLM, Nationwide Children's Hospital
34222 Lipoprotein(a) could be the next public health revolution: Are clinical laboratories ready for the challenge?
Moderator: Leslie Donato, PhD, DABCC, Mayo Clinic
Speaker(s):
The challenging task of measuring and interpreting Lp(a) concentrations for cardiovascular risk prediction
Leslie Donato, PhD, DABCC, Mayo Clinic
Phase 3 trials for Lp(a)-lowering drugs and how the results will affect laboratory test expectations and demands
Sotirios Tsimikas, MD, University of California, San Diego
Roadmap to Lp(a) test standardization with the next generation IFCC-endorsed standard reference measurement system for apolipoprotein(a)
Christa Cobbaert, PhD, EuSpLM, Leiden University Medical Center
34223 From bench to boardroom: Crafting business plans that drive laboratory strategy
Moderator: Y. Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
Speaker(s):
Speaking the language of leadership: Understanding key financial and strategic concepts for laboratory professionals
Melissa Allen, MS, University of Rochester
From proposal to approval: Case-based approaches to crafting compelling laboratory business plans
Y. Victoria Zhang, PhD, MBA, DABCC, FADLM, University of Rochester Medical Center
34224 “Speed dating” with peers to identify and implement process improvements in the clinical laboratory
Moderator: Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
Speaker(s):
Breaking Bad (practices): Don't let delays derail your glucose results
Mark Marzinke, PhD, DABCC, FADLM, Johns Hopkins University
Game of TATs: The rise of latent clotters
Maxwell Harsha, PhD, Johns Hopkins University School of Medicine
Stranger (PT)hings: When proficiency testing goes wrong
Claire Knezevic, PhD, DABCC, NRCC, FADLM, Ann & Robert H. Lurie Children's Hospital of Chicago
34225 Confronting antimicrobial susceptibility testing challenges: Tools from CLSI
Moderator: Alexandra Bryson, PhD, VCU Health
Speaker(s):
Breakpoints: The latest developments and what these mean for the clinical laboratory
Elizabeth Palavecino, MD, Wake Forest University School of Medicine
Developing an antimicrobial susceptibility testing strategy for multidrug-resistant gram-negative rods
Alexandra Bryson, PhD, VCU Health
Don’t wait: Methods for faster antimicrobial susceptibility testing
Elizabeth Garrett, PhD, D(ABMM), Hershey Medical center
34226 Best practices for incorporating gender diversity and inclusion in pathology and laboratory medicine
Moderator: Dina Greene, PhD, DABCC, Evergreene
Speaker(s):
A case-based approach to applying sex-specific reference intervals to a gender diverse population
Dina Greene, PhD, DABCC, Evergreene
Adapting laboratory informatics to see beyond a gender binary
Matthew Krasowski, MD, PhD, University of Iowa Hospitals and Clinics
Guidelines in context: How restrictive gender policies affect implementation of best practices
Tiffany Thomas, PhD, Columbia University
34227 Current and future landscape of tumor markers in clinical use: Applications, challenges, and perspectives
Moderator: Qing Meng, MD, PhD, DABCC, FADLM, University of Texas/MD Anderson Cancer Center
Speaker(s):
Recent advances in biochemical tumor marker testing
Qing Meng, MD, PhD, DABCC, FADLM, University of Texas/MD Anderson Cancer Center
A fluid approach: The promise and pitfalls of liquid biopsies
Vera Paulson, MD, PhD, University of Washington
Liquid biopsy for precision medicine
Klaus Pantel, MD, University of Hamburg-Eppendorf
34228 Alternative sampling for rapid toxicology screening by mass spectrometry
Moderator: William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
Speaker(s):
Noninvasive toxicology screening using the MS pen and HRMS
William Clarke, PhD, MBA, DABCC, FADLM, Johns Hopkins University School of Medicine
Rapid toxicology screening for novel benzodiazepines and opioids by DART-MSMS
Joshua DeBord, PhD, Center for Forensic Science Research and Education
A novel DESI MS-based screening method for ultra-rapid detection of drugs metabolites in urine
Patrice Ohouo, PhD, NRCC, MLS(ASCP), CleanSlate Centers
THURSDAY, JULY 30, 2026
35101 Beyond blood: The frontier of noninvasive fluid diagnostics
Moderator: Steven Cotten, PhD, DABCC, NRCC, FADLM, University of North Carolina
Speaker(s):
What would you do? A body fluid game
Darci Block, PhD, DABCC, Mayo Clinic
No needles? No problem! Navigating noninvasive diagnostics
Chamindie Punyadeera, PhD, Griffith University
35102 Advancing equity in maternal drug testing: From ethical challenges to informatics solutions
Moderator: Vahid Azimi, MD, Kaiser Permanente
Speaker(s):
From policy to practice: A case study in advancing racial equity in maternal urine drug testing
Lauren Nacke, MSW, LCSW, Washington University School of Public Health
Operationalizing equity: Laboratory and informatics strategies for implementing maternal drug testing policy change
Vahid Azimi, MD, Kaiser Permanente
Applying clinical chemistry and informatics to promote fairness in prenatal drug testing
Joyce Liao, PhD, DABCC, University of Washington
35103 Update on thyroid function tests and efforts to improve their reliability
Moderator: Uliana Danilenko, PhD, Centers for Disease Control and Prevention
Speaker(s):
Reference ranges for thyroid function and challenges in diagnosis and monitoring of hypothyroidism
Brian Kim, MD, University of Chicago
Diagnostic approaches to autoimmune thyroid conditions
Trevor Angell, MD, Keck School of Medicine of USC
Current state of FT4 and TSH testing and standardization activities
Uliana Danilenko, PhD, Centers for Disease Control and Prevention
35104 Impact and stewardship of advanced molecular microbiology testing: Making metagenomics matter in infectious disease diagnostics
Moderator: Nicole Pecora, MD, PhD, D(ABMM), Brigham and Women's Hospital/Harvard Medical School
Speaker(s):
Plasma metagenomics for infectious disease diagnosis: Clinical utility and practical approaches to stewardship
Zoe Weiss, MD, Tufts Medical Center
Metagenomics beyond blood: Evolving applications in respiratory, orthopedic and other infections
Nicole Pecora, MD, PhD, D(ABMM), Brigham and Women's Hospital/Harvard Medical School
35105 Insights from the third edition of CLSI C46 (2026): Blood gas and related measurements
Moderator: Xander Van Wijk, DABCC, FADLM, University of California San Francisco
Speaker(s):
Expert presenter 1
Gerald Zavorsky, PhD, RRT, FACSM, University of California, Davis
Expert presenter 2
John Toffaletti, PhD, DABCC, Duke University Medical Center
Expert presenter 3
Xander Van Wijk, DABCC, FADLM, University of California San Francisco
35106 Fundamentals of interacting with vendors: Friends or frenemies?
Moderator: Edmunds Reineks, MD, PhD, DABCC, FCAP, Cleveland Clinic
Speaker(s):
Case studies in vendor interactions with point-of-care programs: From “nobody wants this” to “everything, everywhere all at once”
Edmunds Reineks, MD, PhD, DABCC, FCAP, Cleveland Clinic
Vendor engagement: Do’s and don'ts for successful project initiatives and operations
Ruhan Wei, PhD, DABCC, NRCC, Duke University Medical Center